GGT

DRUG3 trials

Sponsors

Laboratory of Endocrine and Metabolism of West China Hospital, Sichuan University, Gachon University Gil Oriental Medical Hospital, National Taiwan University Hospital

Conditions

Helicobacter Pylori InfectionMetabolic SyndromeObesityType 2 diabetes

Phase 1

Serum gamma-glutamyltransferase, Ferritin, uric acid and their interaction on the risk of type 2 diabetes

Active, not recruitingChiCTR-OCS-09000361

Laboratory of Endocrine and Metabolism of West China Hospital, Sichuan UniversityType 2 diabetes

Start: 2007-06-01Updated: 2017-04-18

Phase 4

Genotypic Resistance Guided Versus Susceptibility Testing Guided Therapy for the First-line Eradication of H. Pylori

National Taiwan University HospitalHelicobacter Pylori Infection

Start: 2018-03-29End: 2022-06-30Target: 560Updated: 2018-10-30

Unknown Phase

Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With or Without Metabolic Syndrome Risk Factors - A Study Protocol for a Double-blind, Randomised, Multi-center, Placebo-controlled Clinical Trial

CompletedNCT03479346

Gachon University Gil Oriental Medical HospitalMetabolic Syndrome, Obesity

Start: 2018-04-28End: 2020-12-01Updated: 2021-04-12

Related Papers

Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials.

2023-05-1024 citations

Vitamin D and Incidence of Prediabetes or Type 2 Diabetes: A Four-Year Follow-Up Community-Based Study

Disease Markers2018-01-0155 citations